🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Pilot Study: KeraStat® Gel for Topical Delivery of Morphine for Management of Non-Healing, Painful Open Wounds and Ulcers

RecruitingPhase 4Ages 18 Years - anyAllThe Metis Foundation
NCT05217160 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This study is intended to provide information from subjects who currently have painful, chronically open wounds and assess the pain reduction capacity of KeraStat® Gel with Morphine. In gathering data from subjects who have baseline pain from their chronically open wounds, the investigators can then evaluate the capacity of KeraStat® Gel plus Morphine in reducing the subjects daily pain levels, pain associated with dressing changes, and pain medication consumption.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. Subjects age 18 or older able to provide informed consent. 2. Ulcer size 1-300 cm2 4\. Undermining/tunneling \<3 cm from wound margin 5. Grossly free of necrotic and/or infected tissue 6. Baseline minimum of 2 on VAS pain scale Exclusion Criteria: Subjects who meet any of the following criteria will be excluded from the study: 1. Known allergy to the standard of care or any of the ingredients in KeraStat® Gel or to morphine 2. Wound has heavy or high-volume exudate or necrotic tissue 3. Clinical signs of infection or contamination of the wound 4. Subjects unable to complete the VAS pain score in pain journal 5. Pregnant or nursing 6. Prisoner 7. Any condition the Investigator determines will compromise subject safety or prevent the subject from completing the study
💊

What it tests

  • KeraStat® Gel with Morphine application
  • KeraStat® Gel application
📍

Where

1 site
South Texas Aesthetic and Reconstructive Surgery
San Antonio, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy